SUSAN CAPPLEMAN: Open Payments
NPI 1639140718 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 25 payments from 14 companies in 2025. Trend: 2023 $180 · 2024 $455 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Corcept Therapeutics | 3 | $60 |
| ABBVIE INC. | 3 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
Products named: TWIIST, Korlym, AIRSUPRA, BREZTRI, TZIELD, Auvelity, MINIMED 780G, Omnipod.
Industry payments across MS — which companies pay providers there.
